Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;41(3):266-324.
doi: 10.1002/npr2.12193. Epub 2021 Aug 12.

Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia"

Japanese Society of Neuropsychopharmacology

Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia"

Japanese Society of Neuropsychopharmacology. Neuropsychopharmacol Rep. 2021 Sep.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Positioning and context of first‐episode psychosis included in this guideline (schizophrenia spectrum and other psychotic disorders in the Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnostic criteria)
FIGURE 2
FIGURE 2
Structure and significance of CQs in Chapter 4
See this image and copyright information in PMC

References

    1. Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004;161(2 Suppl): 1–56. - PubMed
    1. Salimi K, Jarskog LF, Lieberman JA. Antipsychotic drugs for first‐episode schizophrenia: a comparative review. CNS Drugs. 2009;23:837–55. - PubMed
    1. Buchanan RW, Kreyenbuhl J, Kelly DL, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010;36:71–93. - PMC - PubMed
    1. Hasan A, Falkai P, Wobrock T, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012;13:318–78. - PubMed
    1. Leucht S, Tardy M, Komossa K, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta‐analysis. Lancet. 2012;379:2063–71. - PubMed

Publication types